Live Breaking News & Updates on Institute Vaccine|Page 5

Stay updated with breaking news from Institute vaccine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UK says Oxford vaccine review ongoing, won't be approved until safety, efficacy standards met


Text Size:
A+
New Delhi: The review of Oxford University’s Covid-19 vaccine candidate is “ongoing”, said the UK’s top drug regulatory agency Monday. 
The UK became the first country to approve and roll out Pfizer’s Covid-19 vaccines. It has already begun the first Covid-19 vaccination programme in the world, with vaccine shots of the Pfizer/BioNTech product being given to elderly people and healthcare workers.
Now, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is reportedly planning to approve Oxford University-AstraZeneca’s vaccine before the end of this year. 
The move is likely to boost the vaccine candidate’s chances of getting the necessary approvals in India. ....

United Kingdom , New Delhi , Narendra Modi , Novavax Covid , Oxford Astrazeneca Covid , Oxford Covid , Regulatory Agency , Central Drugs Standard Control Organisation , Institute Vaccine , Oxford University Covid , Serum Institute Of India As , Commission On Human Medicines , Serum Institute , Serum Institute Of India , Oxford University , Prime Minister Narendra Modi , Oxford University Astrazeneca , Human Medicines , Pune Based Serum Institute , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , நரேந்திர மோடி , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , நிறுவனம் தடுப்பூசி , சீரம் நிறுவனம் ஆஃப் இந்தியா என , தரகு ஆன் மனிதன் மருந்துகள் ,